Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Synthetic Biologics Inc (NYSE MKT LLC:SYN)

0.6068
Delayed Data
As of May 26
 +0.0148 / +2.50%
Today’s Change
0.41
Today|||52-Week Range
2.25
-20.43%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization20.0K54.0K46.0K57.0K
 
 
 
 
 
 
Operating ExpensesGross Income-20.0K-54.0K-46.0K-57.0K
 
 
 
 
 
General Expenses9.3M9.1M10.2M8.1M
 
 
 
 
 
Research And Development7.2M7.1M6.7M6.1M
 
 
 
 
 
Total Operating Expenses9.3M9.2M10.2M8.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-9.3M-9.2M-10.2M-8.1M
 
 
 
 
 
Extraordinary Credit3.5M666.0K7.7M5.1M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-5.8M-8.5M-2.5M-3.1M
 
 
 
 
 
Minority Interest-82.0K-136.0K-97.0K-212.0K
 
 
 
 
 
Net Income-5.7M-8.4M-2.4M-2.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS91.0M91.4M103.8M117.4M
 
 
 
 
 
Shares To Calculate EPS Diluted93.9M91.4M103.8M117.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.10-$0.09-$0.02-$0.02
 
 
 
 
 
EPS Diluted-$0.10-$0.09-$0.02-$0.02